CorMedix Inc.

NASDAQ: CRMD · Real-Time Price · USD
12.91
0.30 (2.38%)
At close: Aug 15, 2025, 3:59 PM
12.93
0.15%
After-hours: Aug 15, 2025, 07:54 PM EDT

CorMedix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
121.48M 82.55M 43.47M 12.57M 1.11M 304.11K 304.11K 29.7K 36.52K 57.77K 65.41K 92.1K 123.37K 110.31K 190.94K 190.25K 245.19K 253.44K
Cost of Revenue
5.32M 3.97M 3.19M 2.07M 1.43M 974.66K 205.56K 152.46K 102.07K 51.65K 3.73K 51.34K 75.03K 89.13K 148.94K 158.16K 212.91K 217.67K
Gross Profit
116.16M 78.59M 40.28M 10.5M -323.52K -670.55K 98.55K -122.76K -65.55K 6.12K 61.67K 40.77K 48.34K 21.19K 42K 32.09K 32.27K 35.77K
Operating Income
49.32M 14.47M -22.36M -50.96M -58.14M -54.64M -48.96M -41.68M -38.17M -34.61M -30.62M -30.01M -31.62M -29.26M -29.44M -27.74M -25.78M -28.82M
Interest Income
2.46M 2.29M 2.58M 2.99M 3.2M 3.09M 2.68M 1.95M 1.27M 758.65K 326.02K 146.88K 56.48K 24.48K 14.4K 12.98K 20.8K 56.06K
Pretax Income
51.68M 17.18M -19.32M -47.54M -54.51M -51.63M -46.34M -39.79M -36.9M -33.82M -30.29M -29.87M -31.59M -29.28M -29.46M -27.76M -25.79M -28.86M
Net Income
51.16M 17.18M -17.93M -46.15M -53.12M -50.24M 394.84M 401.56M 404.56M 408.23M -29.42M -29.18M -31M -28.03M -28.21M -26.51M -24.54M -23.69M
Selling & General & Admin
3.16B 57.81M 58.7M 56.65M 51.12M 43.19M 35.75M 28M 24.82M 22.86M 20.01M 18.98M 18.19M 16.5M 16.35M 15.58M 15.44M 15.31M
Research & Development
2.45B 6.3M 3.94M 4.5M 6.44M 10.59M 13.16M 13.71M 13.38M 11.8M 10.68M 11.07M 13.47M 12.78M 13.13M 12.19M 10.38M 13.54M
Other Expenses
-5.54B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
66.85M 64.11M 62.64M 61.15M 57.57M 53.77M 48.9M 41.71M 38.21M 34.66M 30.69M 30.06M 31.67M 29.28M 29.48M 27.77M 25.81M 28.86M
Interest Expense
36.69K 36.58K 36.41K 32.95K 36.06K 35.35K 34.3K 36.52K 32.18K 29.91K 26.52K 23.12K 19.72K 16.14K 15.94K 15.89K 18.31K 32.13K
Selling & Marketing Expenses
-6.36B 26.87M 28.74M 28.63M 25.94M 21.81M 15.47M 7.31M 3.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
72.17M 68.08M 65.83M 63.22M 58.95M 54.64M 48.96M 41.71M 38.21M 34.67M 30.69M 30.06M 31.69M 29.32M 29.58M 27.93M 26.03M 29.07M
Income Tax Expense
521.51K n/a -1.39M -1.39M -1.39M -1.41M -441.19M -441.37M -441.48M -442.05M -872.27K -686.62K -573.02K -1.24M -1.23M -1.31M -1.31M -5.23M
Shares Outstanding (Basic)
67.93M 65.24M 61.51M 58.83M 57.62M 57.5M 57.39M 56.55M 45.37M 44.03M 41.18M 40.32M 39.76M 38.25M 37.16M 38.11M 38.08M 36.33M
Shares Outstanding (Diluted)
71.92M 68.98M 61.51M 58.83M 57.62M 57.5M 57.39M 56.55M 45.37M 44.09M 41.86M 41.18M 39.76M 38.25M 38.11M 38.11M 38.08M 36.33M
EPS (Basic)
0.78 0.24 -0.33 -0.81 -0.93 -0.93 9.10 9.17 9.17 9.23 -0.73 -0.75 -0.8 -0.73 -0.75 -0.73 -0.73 -0.75
EPS (Diluted)
0.75 0.22 -0.33 -0.81 -0.93 -0.93 9.09 9.16 9.17 9.23 -0.72 -0.73 -0.79 -0.72 -0.74 -0.73 -0.73 -0.75
EBITDA
52.33M 17.78M -18.83M -47.18M -54.21M -51.39M -46.11M -39.55M -36.66M -33.58M -30.09M -29.7M -31.45M -29.19M -29.37M -27.62M -25.65M -28.7M
EBIT
51.72M 17.22M -19.29M -47.51M -54.47M -51.6M -46.3M -39.76M -36.87M -33.79M -30.26M -29.85M -31.57M -29.26M -29.44M -27.74M -25.77M -28.82M
Depreciation & Amortization
611.44K 561.83K 457.36K 339.03K 276.18K 213.59K 205.56K 206.43K 207.03K 207.87K 209.04K 284.79K 251.58K 213.95K 177.02K 127.57K 118.52K 123.96K